Literature DB >> 12834891

Tunicamycin inhibits NMDA and AMPA receptor responses independently of N-glycosylation.

Keishi Maruo1, Tetsu Nagata, Satoshi Yamamoto, Kaoru Nagai, Yukio Yajima, Soji Maruo, Tomoyuki Nishizaki.   

Abstract

In a whole-cell patch-clamp configuration, currents through N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor channels were monitored in cultured rat hippocampal neurons, and those currents were depressed to 25 and 28% of basal levels, respectively, by 3-min treatment with tunicamycin (10 microM), an inhibitor of protein N-glycosylation. Tunicamycin (10 microM) reduced amplitude of population spikes elicited in the dentate gyrus of rat hippocampal slices, reaching 78% of basal levels 60 min after the beginning of treatment, and long-term potentiation (LTP) of the perforant path was never induced in the presence of tunicamycin. Tunicamycin, thus, appears to serve as a modulator for NMDA and AMPA receptors, regardless of N-glycosylation, thereby inhibiting neurotransmission and LTP in the dentate gyrus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834891     DOI: 10.1016/s0006-8993(03)02838-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  HNK-1 glyco-epitope regulates the stability of the glutamate receptor subunit GluR2 on the neuronal cell surface.

Authors:  Ippei Morita; Shinako Kakuda; Yusuke Takeuchi; Satsuki Itoh; Nana Kawasaki; Yasuhiko Kizuka; Toshisuke Kawasaki; Shogo Oka
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

Review 2.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

3.  Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivo.

Authors:  Gary P Brennan; Eva M Jimenez-Mateos; Ross C McKiernan; Tobias Engel; Guri Tzivion; David C Henshall
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.